These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7693234)

  • 1. [Initial experiences with HCV detection and confirmation tests of the 3rd generation].
    Knödler B; Kühnl P
    Beitr Infusionsther; 1993; 31():10-5. PubMed ID: 7693234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
    Hugo T; Wüst T; Beeser HP
    Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbott HCV EIA 2nd generation: a new screening assay.
    Weise W; Bäcker U; Seidl S; Flacke H; Sondag D; Pirenne H; Schroeter E; Troonen H; Broeksma C; Heyermann H
    Beitr Infusionsther; 1992; 30():34-7. PubMed ID: 1284729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 7 anti-hepatitis C virus enzyme immunoassays of the 2nd generation in blood donation services].
    Gabriel C; Blauhut B
    Beitr Infusionsther; 1993; 31():16-20. PubMed ID: 7693247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
    Melve GK; Myrmel H; Eide GE; Hervig T
    Transfusion; 2009 Nov; 49(11):2359-65. PubMed ID: 19702654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies to HCV: comparison of a c100-3 EIA and the 2nd generation EIA.
    Polywka S; Kaars-Wiele P; Schroeter E; Mandler J; Laufs R
    Beitr Infusionsther; 1992; 30():42-5. PubMed ID: 1284750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Ann Biol Clin (Paris); 1992; 50(5):329-36. PubMed ID: 1485690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HCV antibody test methods and patterns of antibody response].
    Yahagi N; Kitsugi K
    Rinsho Byori; 1991 Jun; 39(6):578-85. PubMed ID: 1652659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays: Wellcozyme VK45 and Ortho 2.0.
    Vrielink H; van der Poel CL; Reesink HW; Lelie PN
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):164-7. PubMed ID: 7543783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A; White KL; Beecham BD; Leschinsky DP; Foley BP; Dockter J; Giachetti C; Safranek TJ
    J Clin Virol; 2006 Jan; 35(1):21-5. PubMed ID: 15921955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
    Monteleone PM; Andrzejewski C; Kelleher JF
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.